Myovant Sciences Ltd.
MYOVDelisted Mar 10, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001679082
Myovant Sciences Ltd. was delisted on Mar 10, 2023; its insiders filed their last Form 4 on Mar 10, 2023; 118 institutions reported holding it in 13F filings for Q4 2022, worth $1.12B in total; no superinvestor held it.
Q4 2022 vs. Q3 2022
How the institutions holding Myovant Sciences Ltd. changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Of which not filed for Q4 2022 | Q4 2022 | Change |
|---|---|---|---|---|
| Holders | 98 | 4 | 118 | +24 |
| Shares | 28.5M | 61.3K | 41.7M | +13.3M (+46.8%) |
| Value | $511.5M | $1.10M | $1.12B | +$613.3M (+120.2%) |
4 institutions that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (55)
Institutions that held Myovant Sciences Ltd. at the end of Q4 2022 but not at the end of Q3 2022.
Sold out (31)
Institutions that held Myovant Sciences Ltd. at the end of Q3 2022 and filed for Q4 2022 without it.
Not filed for Q4 2022 yet (4)
Institutions that held Myovant Sciences Ltd. at the end of Q3 2022 and haven't filed a 13F for Q4 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| ACT Capital Management, LLC | 60,000 | $1.08M |
| FourThought Financial, LLC | 1,000 | $18.0K |
| American Portfolios Advisors | 219 | $3.93K |
| Wipfli Financial Advisors LLC, | 97 | $2.00K |